Arthrex receives FDA clearance for pediatric indication of ACL implant

Hide

Accessibility Tools

Light Mode
Contrast Mode
Grey Mode
Increase Font Size
Decrease Font Size
Reset Font Default
Accessibility Options
Back to Main Site

Dr. John Bradfield Heinrich, Orthopedic Sports Medicine & Joint Replacement Specialist, Dallas, Plano, TX / Media / Healthcare News » Arthrex receives FDA clearance for pediatric indication of ACL implant

Posted on: 20 March, 2023

Source: Healio

Arthrex Inc. has announced FDA clearance of its TightRope implant for use in pediatric patients with ACL injuries, according to a company press release.